SIRPA and type 1 diabetes mellitus: As such, reduction of SIRPα and/or CD47 expression has been suggested to increase APC activation, proliferation, and phagocytic capacity (Figure 2A), characteristic of pro-inflammatory T1D-associated M1 macrophage polarization (31, 46–48, 54–56).